| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2023-02-14 | Rosetta Capital I, LP | Forward Pharma A/S | 5,296,510 | 5.3% | EDGAR |
| SC 13G | 2022-12-29 | StepStone Group LP | Forward Pharma A/S | 13,709,598 | 13.8% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 3,543,432 | 3.6% | EDGAR |
| SC 13G/A | 2021-02-16 | Newtyn Management, LLC | Forward Pharma A/S | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-11 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 5,052,310 | 5.3% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 6,719,416 | 7.1% | EDGAR |
| SC 13G | 2020-02-14 | Newtyn Management, LLC | Forward Pharma A/S | 426,700 | 6.3% | EDGAR |
| SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 8,494,376 | 9.0% | EDGAR |
| SC 13G/A | 2018-05-04 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 8,564,226 | 9.1% | EDGAR |
| SC 13G/A | 2018-02-09 | BAUPOST GROUP LLC/MA | Forward Pharma A/S | 2,848,003 | 3.0% | EDGAR |
| SC 13G | 2018-01-03 | BIOTECHNOLOGY VALUE FUND L P | Forward Pharma A/S | 4,817,306 | 5.1% | EDGAR |
| SC 13G | 2015-02-13 | Nordic Biotech K/S | Forward Pharma A/S | 12,125,340 | 26.1% | EDGAR |
| SC 13G | 2015-02-13 | Rosetta Capital I, LP | Forward Pharma A/S | 8,788,200 | 18.9% | EDGAR |
| SC 13G | 2014-11-10 | BAUPOST GROUP LLC/MA | Forward Pharma A/S | 5,367,300 | 11.7% | EDGAR |